Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 141.30 4.40
Tata Mot 428.65 4.24
Bhel 181.05 3.10
Tata Stl 418.80 1.22
Ntpc Ltd 123.05 0.37
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Piramal Enterprises Limited
Piramal Enterprises Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500302NSE:PELBloomberg:PIEL@INReuters:NICH.BO
Market Lot: 1Face Value: 2ISIN Demat: INE140A01024
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
17-APR-14 Piramal Enterprises today announced that it has agreed to acquire an effective 20% equity stake in Shriram Capital, a financial services company, for an aggregate consideration of Rs 20.14 billion. 10-APR-14 Piramal Enterprises today announced that it has agreed to divest its entire equity stake, comprising 45,425,328 shares (11%), in Vodafone India to Prime Metals, an indirect subsidiary of Vodafone Group Plc, for a total considerat...   More..
Business Profile Future Plans
CEO Talk
Nicholas Piramal is confident that it will survive in the post-2005 era, when product patents become effective as it aims to partner multinational companies.   Vijay Shah
One To One
Recent news
Latest News
Piramal to buy 20% stake in Shriram Capital for Rs 20.14 bn  -IRIS 17-Apr-14
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 13198.7013803.7010962.50
Other Income1968.801592.402547.30
Total Income15167.5015396.1013509.80
Cost of goods sold12896.6015292.9010107.00
OPBDIT2270.90103.203402.80
PAT-1686.10-2315.601307.20
Gross Block---
Equity capital345.10345.10345.10
EPS (Rs.)--13.407.70
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NA44.16 - 63.05
Debt / Equity (x)---
Operating margin (% of OI)15.0 0.725.2
Net margin (% of OI)-11.1-15.0 9.7
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Piramal Tower Annexe
Ganpatrao Kadam Marg
Lower Parel
Mumbai
Maharashtra-400 013
PHONE
(022) 3046 7953
FAX
(022) 2490 2363
 
Board of Directors
Board Meetings
Date Purpose
05-MAY-14 Audited Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer